Green Cross Holdings Preference Shares Market Cap ($2.77 Million)
Market Cap & Net Worth: Green Cross Holdings Preference Shares (005257)
Green Cross Holdings Preference Shares market cap. Green Cross Holdings Preference Shares (KO:005257) has a market capitalization of $2.77 Million (₩4.09 Billion) as of November 3, 2026. Listed on the KO stock exchange, this Korea-based company holds position #29604 globally and #2090 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Green Cross Holdings Preference Shares's stock price ₩17000.00 by its total outstanding shares 240657 (240.66K). Also see cash efficiency ratio of Green Cross Holdings Preference Shares for how efficiently the company converts equity into cash flow.
Green Cross Holdings Preference Shares Market Cap History (2015–2026)
Green Cross Holdings Preference Shares market cap history from 2015 to 2026. Data shows change from $3.96 Million to $2.77 Million (-2.50% CAGR). Check 005257 stock price for real-time trading data and today's change.
Green Cross Holdings Preference Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Green Cross Holdings Preference Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Green Cross Holdings Preference Shares to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Green Cross Holdings Preference Shares's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $3.22 Million | $1.35 Trillion | $47.18 Billion | 0.00x | 0.00x |
| 2017 | $4.11 Million | $1.46 Trillion | $43.36 Billion | 0.00x | 0.00x |
| 2018 | $2.53 Million | $1.55 Trillion | $18.47 Billion | 0.00x | 0.00x |
| 2019 | $2.85 Million | $1.52 Trillion | $2.96 Billion | 0.00x | 0.00x |
| 2020 | $20.18 Million | $1.72 Trillion | $170.96 Billion | 0.00x | 0.00x |
| 2021 | $8.09 Million | $1.84 Trillion | $55.27 Billion | 0.00x | 0.00x |
| 2022 | $5.32 Million | $2.08 Trillion | $32.82 Billion | 0.00x | 0.00x |
| 2023 | $5.09 Million | $2.06 Trillion | -$54.14 Billion | 0.00x | N/A |
| 2024 | $3.86 Million | $2.20 Trillion | $24.03 Billion | 0.00x | 0.00x |
| 2025 | $4.30 Million | $2.45 Trillion | -$69.51 Billion | 0.00x | N/A |
Competitor Companies of 005257 by Market Capitalization
Companies near Green Cross Holdings Preference Shares in the global market cap rankings as of November 3, 2026. Also see balance sheet size of Green Cross Holdings Preference Shares for a full breakdown of the balance sheet.
Key companies related to Green Cross Holdings Preference Shares by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #372 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #411 globally with a market cap of $69.05 Billion USD ( AU$97.59 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #497 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $553.15 |
| #372 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $961.26 |
| #411 | CSL Ltd | AU:CSL | $69.05 Billion | AU$201.16 |
| #497 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $220.83 |
Market Capitalization of Green Cross Holdings Preference Shares (2015–2026)
Market capitalization of Green Cross Holdings Preference Shares from 2015 to today. Between 2015 and today, Green Cross Holdings Preference Shares's market cap moved from $3.96 Million to $ 2.77 Million, with a yearly change of -2.50%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩2.77 Million | -35.48% |
| 2025 | ₩4.30 Million | +11.42% |
| 2024 | ₩3.86 Million | -24.20% |
| 2023 | ₩5.09 Million | -4.40% |
| 2022 | ₩5.32 Million | -34.20% |
| 2021 | ₩8.09 Million | -59.92% |
| 2020 | ₩20.18 Million | +607.67% |
| 2019 | ₩2.85 Million | +12.74% |
| 2018 | ₩2.53 Million | -38.46% |
| 2017 | ₩4.11 Million | +27.73% |
| 2016 | ₩3.22 Million | -18.80% |
| 2015 | ₩3.96 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Green Cross Holdings Preference Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.77 Million USD |
| MoneyControl | $2.77 Million USD |
| MarketWatch | $2.77 Million USD |
| marketcap.company | $2.77 Million USD |
| Reuters | $2.77 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Green Cross Holdings Preference Shares
GC Corp. operates as a biotechnology company. The company provides prescription drugs and over-the-counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and… Read more